Abstract
In the context of a clinical trial, we observed a surprisingly high methicillin resistant S. aureus (MRSA) eradication rate of a placebo solution containing a cationic polymeric compound (CPC). The most active compound altering bacterial growth was identified by testing individually all molecules entering the composition of the commercial solution.
Highlights
In the context of a clinical trial, we observed a surprisingly high methicillin resistant S. aureus (MRSA) eradication rate of a placebo solution containing a cationic polymeric compound (CPC)
The most active compound altering bacterial growth was identified by testing individually all molecules entering the composition of the commercial solution
Polyhexanide was rapidly bactericidal for all tested MRSA strains; a rapid decrease of >5 logs in 15 min was generally observed
Summary
In the context of a clinical trial, we observed a surprisingly high methicillin resistant S. aureus (MRSA) eradication rate of a placebo solution containing a cationic polymeric compound (CPC). The most active compound altering bacterial growth was identified by testing individually all molecules entering the composition of the commercial solution
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.